Form 4: SANUWAVE Health Director James Tyler Receives Stock Option Grant
Insider Transaction Report
SANUWAVE Health, Inc. Director James Tyler has been granted 1,574 stock options, aligning his interests with shareholders.
Summary
- Director James Tyler of SANUWAVE Health, Inc. (SNWV) acquired 1,574 stock options.
- The transaction date for the option grant was June 30, 2025.
- Each stock option has an exercise price of $32.86.
- The options were fully vested at the grant date, June 30, 2025.
- The expiration date for these stock options is June 30, 2030.
- The options allow for the purchase of 1,574 shares of Common Stock.
- The price of the derivative security (the option itself) was $0, indicating it was a grant.
Sentiment
Score: 7
Explanation: The grant of stock options to a director is generally viewed positively as it aligns management's interests with shareholders, incentivizing long-term value creation. The number of options is relatively small, so the impact on overall sentiment is moderate.
Positives
- The grant of stock options to Director James Tyler aligns his financial interests with those of the company's shareholders, potentially incentivizing long-term performance.
- The options were fully vested at the grant date, providing immediate equity interest.
Future Outlook
This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
The grant of stock options to directors is a common practice in the healthcare technology industry, used to attract, retain, and incentivize key personnel by aligning their compensation with company performance and shareholder value creation.
Related Party Transactions
- The grant of stock options to James Tyler, a director of SANUWAVE Health, Inc., constitutes a related party transaction.
Stakeholder Impact
- Shareholders: The option grant aligns the director's interests with shareholders, potentially leading to more focused efforts on increasing shareholder value.
- Management/Employees: This type of compensation is a standard incentive mechanism for key personnel.
Next Steps
- The options can be exercised by James Tyler at any time between the grant date and the expiration date, subject to market conditions and personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of earliest transaction and date options were fully vested. |
| 07/02/2025 | Date the Form 4 was signed by the Attorney-in-Fact for James Tyler. |
| 06/30/2030 | Expiration date of the stock options. |
Keywords
SANUWAVE Health, SNWV, Stock Option, Insider Transaction, Director Compensation, Equity Grant, Form 4, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.